BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33021738)

  • 1. Robust methods to correct for measurement error when evaluating a surrogate marker.
    Parast L; Garcia TP; Prentice RL; Carroll RJ
    Biometrics; 2022 Mar; 78(1):9-23. PubMed ID: 33021738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust estimation of the proportion of treatment effect explained by surrogate marker information.
    Parast L; McDermott MM; Tian L
    Stat Med; 2016 May; 35(10):1637-53. PubMed ID: 26631934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating multiple surrogate markers with censored data.
    Parast L; Cai T; Tian L
    Biometrics; 2021 Dec; 77(4):1315-1327. PubMed ID: 32920821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a surrogate marker for early testing of a treatment effect.
    Parast L; Cai T; Tian L
    Biometrics; 2019 Dec; 75(4):1253-1263. PubMed ID: 31009073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust approach to combining multiple markers to improve surrogacy.
    Wang X; Parast L; Han L; Tian L; Cai T
    Biometrics; 2023 Jun; 79(2):788-798. PubMed ID: 35426444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating surrogate marker information using censored data.
    Parast L; Cai T; Tian L
    Stat Med; 2017 May; 36(11):1767-1782. PubMed ID: 28088843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of longitudinal surrogate markers.
    Agniel D; Parast L
    Biometrics; 2021 Jun; 77(2):477-489. PubMed ID: 32506496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the feasibility of shortening clinical trial duration using surrogate markers.
    Wang X; Cai T; Tian L; Bourgeois F; Parast L
    Stat Med; 2021 Dec; 40(28):6321-6343. PubMed ID: 34474500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for heterogeneity in the utility of a surrogate marker.
    Parast L; Cai T; Tian L
    Biometrics; 2023 Jun; 79(2):799-810. PubMed ID: 34874550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible evaluation of surrogate markers with Bayesian model averaging.
    Duan Y; Parast L
    Stat Med; 2024 Feb; 43(4):774-792. PubMed ID: 38081586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying surrogate markers in real-world comparative effectiveness research.
    Han L; Wang X; Cai T
    Stat Med; 2022 Nov; 41(26):5290-5304. PubMed ID: 36062392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the proportion of treatment effect explained by a high-dimensional surrogate.
    Zhou RR; Zhao SD; Parast L
    Stat Med; 2022 May; 41(12):2227-2246. PubMed ID: 35189671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlated errors in biased surrogates: study designs and methods for measurement error correction.
    Spiegelman D; Zhao B; Kim J
    Stat Med; 2005 Jun; 24(11):1657-82. PubMed ID: 15736283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust best linear estimator for Cox regression with instrumental variables in whole cohort and surrogates with additive measurement error in calibration sample.
    Wang CY; Song X
    Biom J; 2016 Nov; 58(6):1465-1484. PubMed ID: 27546625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doubly robust evaluation of high-dimensional surrogate markers.
    Agniel D; Hejblum BP; Thiébaut R; Parast L
    Biostatistics; 2023 Oct; 24(4):985-999. PubMed ID: 35791753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using surrogate biomarkers to improve measurement error models in nutritional epidemiology.
    Keogh RH; White IR; Rodwell SA
    Stat Med; 2013 Sep; 32(22):3838-61. PubMed ID: 23553407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust best linear estimation for regression analysis using surrogate and instrumental variables.
    Wang CY
    Biostatistics; 2012 Apr; 13(2):326-40. PubMed ID: 22285992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal inference with measurement error in outcomes: Bias analysis and estimation methods.
    Shu D; Yi GY
    Stat Methods Med Res; 2019 Jul; 28(7):2049-2068. PubMed ID: 29241426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint nonparametric correction estimator for excess relative risk regression in survival analysis with exposure measurement error.
    Wang CY; Cullings H; Song X; Kopecky KJ
    J R Stat Soc Series B Stat Methodol; 2017 Nov; 79(5):1583-1599. PubMed ID: 29354018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.